Surgical outcomes in patients who received presurgical treatment with pazopanib for advanced renal cell carcinoma with inferior vena cava tumor thrombus; a historical control study
Not Applicable
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-UMIN000034799
- Lead Sponsor
- Kobe university Graduate School of Medicine Division of Urology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who did not participate in this study 2.Patients who participated in other clinical trials within 4 months. 3.Performance Status> 3 4.AST,ALT> 3.0*upper limit of normal range(ULN), or total Bil> 2.0*ULN 5.Patients who receive treatment of other cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method bleeding volume in surgery
- Secondary Outcome Measures
Name Time Method -Improvement of surgical invasion: Outcome of change from surgical procedure expected before surgery to minimally invasive surgical procedure due to tumor reduction. -Operation time -Grade 3 or higher complications -Reduction in the level of tumor embolism according to the classification of Mayo clinic -Reduction rate of primary tumor and metastatic lesion.